Kukje Pharma Co., Ltd. (002720.KS)

KRW 4970.0

(-2.17%)

Market Cap (In KRW)

101.2 Billion

Revenue (In KRW)

135.37 Billion

Net Income (In KRW)

-8.41 Billion

Avg. Volume

2.58 Million

Currency
KRW
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
4365.0-8120.0
PE
-
EPS
-
Beta Value
0.612
ISIN
KR7002720001
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Tae-hoon Nam
Employee Count
-
Website
https://www.kukjepharm.co.kr
Ipo Date
2005-09-29
Details
Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAIDS and other analgesics, gastrointestinal and cardiovascular agents, antidiabetics, genitourinary and respiratory agents, and other ETC products. The company was founded in 1959 and is headquartered in Seongnam, South Korea.